2025
SJR Q3
JCR Q3 · 1,9
12 eşleşen makale
SCIE
Dergi ayrıntısı
Stem Cells and Development
- Yayıncı
- Mary Ann Liebert Inc.
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
1547328715578534
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,532
- Quartile Q3
- H-Index 142
- Atıf/yayın 2
- Doküman (3y) 192
- Atıf (3y) 385
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 1,9
- 5Y JIF 2,6
- JCI 0,55
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Cell Biology Q4
- Developmental Biology Q3
- Hematology Q3
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS kategorileri
- Cell & Tissue Engineering | Hematology | Medicine, Research & Experimental | Transplantation
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q3 | 0,532 | 1,9 | 2,6 | 0,55 | Q2 | 142 |
| 2024 | Q2 | Q2 | 0,723 | 2 | 2,9 | 0,68 | Q2 | 138 |
| 2023 | Q2 | Q2 | 0,803 | 2,5 | 4,4 | 0,87 | Q2 | 138 |
| 2022 | Q2 | Q2 | 0,849 | 4 | 3,8 | 0,96 | Q1 | 138 |
| 2021 | Q2 | Q2 | 0,779 | 4,4 | 4,1 | 0,92 | Q2 | 138 |
| 2020 | Q2 | Q2 | 0,99 | 3,3 | 3,9 | 0,91 | Q1 | 138 |
| 2019 | Q1 | Q2 | 1,09 | 3,2 | 3,5 | 0,95 | Q1 | 138 |
| 2018 | — | Q2 | — | 3,1 | 3,6 | 0,98 | Q2 | — |
| 2017 | Q1 | Q2 | 1,426 | 3,3 | 3,7 | 1,06 | Q1 | 138 |
| 2016 | Q1 | Q2 | 1,594 | 3,6 | 3,8 | — | — | 138 |
| 2015 | Q1 | Q1 | 1,742 | 3,8 | 4 | — | — | 138 |
| 2014 | Q1 | Q1 | 1,625 | 3,7 | 4,1 | — | — | 138 |
| 2013 | Q1 | Q1 | 1,822 | 4,2 | 4,6 | — | — | 138 |
| 2012 | Q1 | Q1 | 1,794 | 4,7 | 4,7 | — | — | 138 |
| 2011 | Q1 | Q1 | 1,758 | 4,5 | 4,4 | — | — | 138 |
| 2010 | Q1 | Q1 | 1,679 | 4,8 | 4,5 | — | — | 138 |
| 2009 | — | Q1 | — | 4,1 | 3,8 | — | — | — |
| 2008 | — | Q1 | — | 3,3 | 3,3 | — | — | — |
| 2007 | — | Q2 | — | 3,2 | 3,5 | — | — | — |
| 2006 | — | Q1 | — | 3,1 | — | — | — | — |
| 2005 | — | Q2 | — | 2,3 | — | — | — | — |
| 2004 | — | — | — | — | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q3 | 29/32 |
| 2025 | HEMATOLOGY | SCIE | Q3 | Q2 | 69/103 |
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 129/191 |
| 2025 | TRANSPLANTATION | SCIE | Q3 | Q3 | 18/30 |
| 2024 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q3 | 29/32 |
| 2024 | HEMATOLOGY | SCIE | Q3 | Q2 | 57/99 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 125/195 |
| 2024 | TRANSPLANTATION | SCIE | Q2 | Q3 | 15/31 |
| 2023 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q2 | 23/31 |
| 2023 | HEMATOLOGY | SCIE | Q2 | Q2 | 41/97 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 101/189 |
| 2023 | TRANSPLANTATION | SCIE | Q2 | Q2 | 14/31 |
| 2022 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q2 | 17/29 |
| 2022 | HEMATOLOGY | SCIE | Q2 | Q1 | 28/79 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 68/136 |
| 2022 | TRANSPLANTATION | SCIE | Q2 | Q2 | 9/26 |
| 2021 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q2 | 16/29 |
| 2021 | HEMATOLOGY | SCIE | Q2 | Q2 | 33/78 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 66/139 |
| 2021 | TRANSPLANTATION | SCIE | Q2 | Q2 | 8/25 |
| 2020 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q2 | 23/29 |
| 2020 | HEMATOLOGY | SCIE | Q3 | Q1 | 40/76 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 84/140 |
| 2020 | TRANSPLANTATION | SCIE | Q2 | Q2 | 12/25 |
| 2019 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q2 | 19/29 |
| 2019 | HEMATOLOGY | SCIE | Q2 | Q1 | 28/76 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 68/139 |
| 2019 | TRANSPLANTATION | SCIE | Q2 | Q2 | 11/24 |
| 2018 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q2 | 17/26 |
| 2018 | HEMATOLOGY | SCIE | Q2 | Q2 | 28/73 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 60/136 |
| 2018 | TRANSPLANTATION | SCIE | Q2 | Q2 | 11/25 |
| 2017 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q1 | 14/24 |
| 2017 | HEMATOLOGY | SCIE | Q2 | Q1 | 24/71 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 51/133 |
| 2017 | TRANSPLANTATION | SCIE | Q2 | Q2 | 9/25 |
| 2016 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 9/21 |
| 2016 | HEMATOLOGY | SCIE | Q2 | — | 23/70 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 34/128 |
| 2016 | TRANSPLANTATION | SCIE | Q2 | — | 9/25 |
| 2015 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 9/21 |
| 2015 | HEMATOLOGY | SCIE | Q2 | — | 20/70 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 28/124 |
| 2015 | TRANSPLANTATION | SCIE | Q2 | — | 8/25 |
| 2014 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 8/21 |
| 2014 | HEMATOLOGY | SCIE | Q2 | — | 18/68 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 29/123 |
| 2014 | TRANSPLANTATION | SCIE | Q1 | — | 6/25 |
| 2013 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 6/18 |
| 2013 | HEMATOLOGY | SCIE | Q1 | — | 15/68 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 21/124 |
| 2013 | TRANSPLANTATION | SCIE | Q1 | — | 3/26 |
| 2012 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 3/17 |
| 2012 | HEMATOLOGY | SCIE | Q1 | — | 12/67 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 20/121 |
| 2012 | TRANSPLANTATION | SCIE | Q1 | — | 3/26 |
| 2011 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 4/12 |
| 2011 | HEMATOLOGY | SCIE | Q1 | — | 17/68 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 17/112 |
| 2011 | TRANSPLANTATION | SCIE | Q1 | — | 2/24 |
| 2010 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 4/13 |
| 2010 | HEMATOLOGY | SCIE | Q1 | — | 12/66 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 16/106 |
| 2010 | TRANSPLANTATION | SCIE | Q1 | — | 3/25 |
| 2009 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 4/12 |
| 2009 | HEMATOLOGY | SCIE | Q2 | — | 16/61 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 18/93 |
| 2009 | TRANSPLANTATION | SCIE | Q1 | — | 3/24 |
| 2008 | HEMATOLOGY | SCIE | Q2 | — | 23/62 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 20/83 |
| 2008 | TRANSPLANTATION | SCIE | Q2 | — | 9/21 |
| 2007 | HEMATOLOGY | SCIE | Q2 | — | 21/63 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 21/81 |
| 2007 | TRANSPLANTATION | SCIE | Q2 | — | 6/21 |
| 2006 | HEMATOLOGY | SCIE | Q2 | — | 21/61 |
| 2006 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 19/76 |
| 2006 | TRANSPLANTATION | SCIE | Q2 | — | 7/19 |
| 2005 | HEMATOLOGY | SCIE | Q2 | — | 27/60 |
| 2005 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 29/72 |
| 2005 | TRANSPLANTATION | SCIE | Q2 | — | 10/20 |
| 2004 | HEMATOLOGY | SCIE | — | — | — |
| 2004 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | — | — | — |
| 2004 | TRANSPLANTATION | SCIE | — | — | — |